Leginsulin alleviates pathological cardiac hypertrophy potentially by regulating the oxidative stress-mediated MAPK signaling pathway
Leginsulin, a naturally occurring soybean-derived peptide, alleviates pathological cardiac hypertrophy and fibrosis by mitigating oxidative stress, preserving mitochondrial function, and selectively suppressing the JNK and ERK branches of the MAPK signaling pathway.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
The human heart is a tireless pump, but like any engine, it can wear out under too much pressure. When the heart is forced to work harder than it should—due to high blood pressure or blocked arteries—the muscle cells inside it begin to grow larger. This condition, known as pathological cardiac hypertrophy, is not a healthy adaptation. Instead of becoming stronger, the heart muscle thickens, stiffens, and eventually fails to pump blood effectively. A major driver of this damage is a state called oxidative stress. Imagine the cells as tiny factories; when they are under stress, they produce too much waste, specifically harmful molecules that damage the machinery. This waste clogs the heart's internal power plants, the mitochondria, causing them to malfunction and produce even more waste in a vicious cycle. Eventually, the heart fills with scar tissue, losing its ability to beat rhythmically. Finding a way to stop this chain reaction before the heart fails is a critical goal for medical science.
Researchers at Hubei University of Technology have turned their attention to a natural substance found in plants to see if it can break this cycle. They focused on a small protein fragment called leginsulin, which is derived from soybeans and peas. While scientists already knew this peptide could help cells manage sugar and protect their internal power plants from damage, its ability to save the heart was a mystery. To test this, the team created a scenario where the heart was under severe stress. They used mice and injected them with a chemical that mimics the intense strain of a heart attack or severe high blood pressure, causing the animals' hearts to enlarge and scar. They then treated some of these mice with leginsulin to see if it could prevent the damage.
The results were striking. In the mice that received the stress-inducing chemical alone, the hearts became significantly larger, and the muscle cells swelled up, losing their organized structure. The heart tissue also became filled with excess collagen, a type of scar tissue that makes the heart stiff. However, the mice that received leginsulin alongside the stress chemical showed a heart that looked much closer to normal. The researchers measured the size of the hearts and found that the treatment prevented the organ from enlarging. When they looked at the muscle cells under a microscope, the treated cells were smaller and more organized than those in the untreated group. Furthermore, the amount of scar tissue in the treated hearts was reduced by nearly half compared to the damaged hearts, suggesting that leginsulin helped the heart maintain its shape and flexibility.
To understand how this happened, the team moved from whole animals to individual heart cells in a dish. They exposed human and rat heart cells to a chemical that triggers the same kind of stress seen in the mice. Without protection, these cells grew larger and began to produce high levels of harmful waste molecules. The researchers found that leginsulin acted as a shield. It stopped the cells from producing excess waste and helped them clear out the damage that had already occurred. Crucially, the treatment kept the cells' internal power plants healthy. In the stressed cells, these power plants lost their electrical charge and stopped making energy, but leginsulin kept them running smoothly, ensuring the cells had the fuel they needed to survive.
The study also traced the specific signals inside the cell that tell the heart to grow and scar. When heart cells are stressed, they activate a set of internal switches known as the MAPK pathway. Think of these switches as a control panel with different levers; some levers tell the heart to grow, while others manage inflammation. The researchers discovered that leginsulin did not turn off the entire control panel. Instead, it selectively pulled down the specific levers responsible for abnormal growth and scarring, while leaving other signals untouched. By stopping these specific growth signals, the peptide prevented the heart cells from reactivating immature genes that cause them to swell and produce scar tissue.
This work suggests that leginsulin offers a multi-layered defense for the heart. It does not just treat one symptom; it addresses the root causes of the damage. By reducing the harmful waste inside the cells, keeping the energy factories working, and stopping the specific signals that trigger scarring, the peptide helps the heart resist the effects of severe stress. While this research was conducted in animals and cells and has not yet been tested in people, it reveals a new potential role for a natural plant peptide. It shows that a substance originally studied for its ability to manage sugar might also be a powerful tool for protecting the heart from the wear and tear that leads to failure. The findings provide a clear map of how a simple protein can interact with complex cellular machinery to preserve heart health, opening the door for future studies on natural treatments for heart disease.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.